115 related articles for article (PubMed ID: 10909994)
1. Streptozotocin-induced diabetic pregnant rats exhibit signs and symptoms mimicking preeclampsia.
Ishihara G; Hiramatsu Y; Masuyama H; Kudo T
Metabolism; 2000 Jul; 49(7):853-7. PubMed ID: 10909994
[TBL] [Abstract][Full Text] [Related]
2. Influence of postnatal overnutrition and pregnancy on non-insulin dependent diabetes induced in Wistar rats by neonatal streptozotocin.
Mende S; Mühle W; Peters WH
Horm Metab Res; 1996 Feb; 28(2):81-5. PubMed ID: 8867903
[TBL] [Abstract][Full Text] [Related]
3. Effects of cadmium exposure on morphological aspects of pancreas, weights of fetus and placenta in streptozotocin-induced diabetic pregnant rats.
Kanter M; Yoruk M; Koc A; Meral I; Karaca T
Biol Trace Elem Res; 2003; 93(1-3):189-200. PubMed ID: 12835501
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of different rat models with co-existing diabetes-mellitus and hypertension.
Hakim ZS; Goyal RK
Indian J Physiol Pharmacol; 2000 Apr; 44(2):125-35. PubMed ID: 10846625
[TBL] [Abstract][Full Text] [Related]
5. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
Adewole SO; Ojewole JA
Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
[TBL] [Abstract][Full Text] [Related]
6. Localization of glycogen in the placenta and fetal and maternal livers of cadmium-exposed diabetic pregnant rats.
Yoruk M; Kanter M; Meral I; Agaoglu Z
Biol Trace Elem Res; 2003; 96(1-3):217-26. PubMed ID: 14716101
[TBL] [Abstract][Full Text] [Related]
7. Different diabetogenic response to moderate doses of streptozotocin in pregnant rats, and its long-term consequences in the offspring.
López-Soldado I; Herrera E
Exp Diabesity Res; 2003; 4(2):107-18. PubMed ID: 14630572
[TBL] [Abstract][Full Text] [Related]
8. Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats.
Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K; Nakahori Y
J Endocrinol; 2009 Jan; 200(1):53-61. PubMed ID: 18931022
[TBL] [Abstract][Full Text] [Related]
9. Insulin and losartan reduce proteinuria and renal hypertrophy in the pregnant diabetic rat.
Natif N; Sclarovsky-Benjaminov F; Van Dijk DJ; Sulkes J; Gafter U; Boner G; Erman A
J Lab Clin Med; 2003 Sep; 142(3):166-71. PubMed ID: 14532904
[TBL] [Abstract][Full Text] [Related]
10. Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat.
van Dijk DJ; Boner G; Giler S; Erman A
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):193-8. PubMed ID: 11881122
[TBL] [Abstract][Full Text] [Related]
11. Maternal-fetal outcome, lipid profile and oxidative stress of diabetic rats neonatally exposed to streptozotocin.
Damasceno DC; Kiss AC; Sinzato YK; de Campos KE; Rudge MV; Calderon IM; Volpato GT
Exp Clin Endocrinol Diabetes; 2011 Jul; 119(7):408-13. PubMed ID: 21667442
[TBL] [Abstract][Full Text] [Related]
12. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.
Koçak G; Aktan F; Canbolat O; Ozoğul C; Elbeğ S; Yildizoglu-Ari N; Karasu C;
Diabetes Nutr Metab; 2000 Dec; 13(6):308-18. PubMed ID: 11232755
[TBL] [Abstract][Full Text] [Related]
13. The relationship between nitric oxide and leptin in the lung of rat with streptozotocin-induced diabetes.
Oztay F; Kandil A; Gurel E; Ustunova S; Kapucu A; Balci H; Akgun-Dar K; Demirci C
Cell Biochem Funct; 2008; 26(2):162-71. PubMed ID: 17542037
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of atenolol and metoprolol on cardiovascular complications associated with streptozotocin-induced diabetic rats.
Bhadada SV; Goyal RK
Can J Physiol Pharmacol; 2007 Aug; 85(8):831-6. PubMed ID: 17901894
[TBL] [Abstract][Full Text] [Related]
15. An experimental model for studies of fetal maldevelopment in the diabetic pregnancy.
Kemnitz JW; Perelman RH; Engle MJ; Farrell PM
Pediatr Pulmonol; 1985; 1(3 Suppl):S79-85. PubMed ID: 4069805
[TBL] [Abstract][Full Text] [Related]
16. Neonatal streptozotocin-induced glucose intolerance: different consequences in Lyon normotensive and hypertensive rats.
Emonnot L; Cohen R; Lo M
J Hypertens; 2007 Feb; 25(2):429-38. PubMed ID: 17211251
[TBL] [Abstract][Full Text] [Related]
17. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
18. Effects of ACE-I on diabetic cardiovascular complications: anti-hypertensive and non-antihypertensive doses.
Udayachalerm W; Vechakarn O; Patumraj S
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S306-13. PubMed ID: 11529349
[TBL] [Abstract][Full Text] [Related]
19. Serotonin enhances beta-endorphin secretion to lower plasma glucose in streptozotocin-induced diabetic rats.
Chi TC; Ho YJ; Chen WP; Chi TL; Lee SS; Cheng JT; Su MJ
Life Sci; 2007 Apr; 80(20):1832-8. PubMed ID: 17397876
[TBL] [Abstract][Full Text] [Related]
20. Neonatal streptozotocin-induced diabetes mellitus: a model of insulin resistance associated with loss of adipose mass.
Takada J; Machado MA; Peres SB; Brito LC; Borges-Silva CN; Costa CE; Fonseca-Alaniz MH; Andreotti S; Lima FB
Metabolism; 2007 Jul; 56(7):977-84. PubMed ID: 17570261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
